NTLA-5001

· Intellia Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NTLA-5001, covering 2023-12-28 to 2023-12-28. Get the full timeline:

Most recent: Clinical Trial Update: Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia [Phase 1, Phase 2]